The store will not work correctly when cookies are disabled.
7-(4'-carbamimidoylbiphenyl-4-yl)-2-naphthimidamide
ID: ALA4856341
PubChem CID: 16126642
Max Phase: Preclinical
Molecular Formula: C24H20N4
Molecular Weight: 364.45
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: N=C(N)c1ccc(-c2ccc(-c3ccc4ccc(C(=N)N)cc4c3)cc2)cc1
Standard InChI: InChI=1S/C24H20N4/c25-23(26)19-9-5-16(6-10-19)15-1-3-17(4-2-15)20-11-7-18-8-12-21(24(27)28)14-22(18)13-20/h1-14H,(H3,25,26)(H3,27,28)
Standard InChI Key: QBQKKMRGHPFHCF-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 31 0 0 0 0 0 0 0 0999 V2000
15.6962 -10.3342 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.1066 -11.0465 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6962 -11.7588 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.1066 -12.4711 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6962 -13.1875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8712 -11.7588 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4608 -12.4711 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.8712 -13.1875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4608 -13.8998 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6358 -13.8998 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.2253 -13.1875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4003 -13.1875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9899 -13.8998 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1649 -13.8998 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7544 -13.1875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9293 -13.1875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5189 -13.8998 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6939 -13.8998 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.2835 -13.1875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.4585 -13.1875 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0480 -13.8998 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.0480 -12.4711 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.6939 -12.4711 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5189 -12.4711 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1649 -12.4711 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9899 -12.4711 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6358 -12.4711 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9316 -11.0465 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 2 0
3 6 2 0
6 7 1 0
7 8 2 0
5 8 1 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 1 0
20 22 2 0
19 23 1 0
23 24 2 0
16 24 1 0
15 25 1 0
25 26 2 0
12 26 1 0
11 27 2 0
7 27 1 0
2 28 2 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 364.45 | Molecular Weight (Monoisotopic): 364.1688 | AlogP: 4.74 | #Rotatable Bonds: 4 |
Polar Surface Area: 99.74 | Molecular Species: BASE | HBA: 2 | HBD: 4 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 6 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: ┄ | CX Basic pKa: 11.69 | CX LogP: 4.10 | CX LogD: -0.71 |
Aromatic Rings: 4 | Heavy Atoms: 28 | QED Weighted: 0.31 | Np Likeness Score: -0.02 |
References
1. Depauw S, Lambert M, Jambon S, Paul A, Peixoto P, Nhili R, Marongiu L, Figeac M, Dassi C, Paul-Constant C, Billoré B, Kumar A, Farahat AA, Ismail MA, Mineva E, Sweat DP, Stephens CE, Boykin DW, Wilson WD, David-Cordonnier MH.. (2019) Heterocyclic Diamidine DNA Ligands as HOXA9 Transcription Factor Inhibitors: Design, Molecular Evaluation, and Cellular Consequences in a HOXA9-Dependant Leukemia Cell Model., 62 (3.0): [PMID:30645099] [10.1021/acs.jmedchem.8b01448] |